RentRedi Launches AI-powered Accounting Suite Designed for Rental Business Owners Who Want Clear, Confident Financials Year-Round
Pushpay Launches New AI Solutions, Turning Ministry Moments into Meaningful Action for the Church
Striim Releases Validata to Ensure Data Accuracy and Deliver Trusted AI
pdfFiller Announces AI Document Creator for Fast, AI-Powered Document Generation
ThoughtSpot Launches Four BI Agents that Work as a Team to Deliver Modern Analytics
Acquisition of Zikani Therapeutics, Ribosomal Modulation Company; Combined Company Advancing Ribosomal RNA-Targeted Genetic Therapies Additional…
BELTSVILLE, Md., May 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE)…
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients,…
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ, May…
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
BOSTON, May 06, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
— Advanced infectious disease vaccine programs with Sanofi Pasteur through initiation of COVID-19 clinical trial…
Health Canada clears the CTA for VOR33 clinical trial Vor to present on VOR33 manufacturing…
– Recommended Phase 2 Dose of IGM-2323 Expected in 2021 – – Initial Data from…
Lead program ORIC-101 on track for two initial Phase 1b data readouts in 2021 Three…
Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for…
– On Track to Report Initial Phase 2 Data From pheNIX PKU Clinical Trial by…
VRDN-001 and VRDN-002 programs for Thyroid Eye Disease (TED) progressing; on track for IND filings…
COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple…
Reports Net Revenues of $103.0 Million for the Three Months Ended March 31, 2021 RANCHO…
Total Revenue up 23% and Product Revenue Doubles Year over Year REDWOOD CITY, Calif., May…